in this issue
People & Business :: M&A
PolyTherics Acquires Warwick Effect Polymers
1:21 PM MST | January 26, 2012 | Deepti Ramesh
PolyTherics (London), a biotechnology company that applies precision chemistry to develop protein and peptide-based drugs, says it has acquired Warwick Effect Polymers (WEP; Coventry, U.K.), a provider of specialty biopolymers for the modification of biological products. Financial details were not disclosed. WEP has developed two proprietary biopolymer technologies, PolyPEG and GlycoPol. WEP has agreements with several global pharmaceutical and biotechnology companies for the evaluation of PolyPEG or GlycoPol and the company expects to announce licensing deals...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee